data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
CytoSorbents
(NASDAQ:CTSO)
2.12
-0.24[-10.17%]
At close: Jun 24
2.36
0.2400[11.32%]
After Hours: 4:01PM EDT
Day High/Low2.1 - 2.38
52 Week High/Low1.69 - 9.8
Open / Close2.34 / 2.12
Float / Outstanding42.6M / 43.6M
Vol / Avg.4.5M / 314.5K
Mkt Cap92.4M
P/E-
50d Avg. Price2.17
Div / Yield-
Payout Ratio-
EPS-0.21
Total Float42.6M

CytoSorbents (NASDAQ:CTSO), Quotes and News Summary

CytoSorbents (NASDAQ: CTSO)

Day High/Low2.1 - 2.38
52 Week High/Low1.69 - 9.8
Open / Close2.34 / 2.12
Float / Outstanding42.6M / 43.6M
Vol / Avg.4.5M / 314.5K
Mkt Cap92.4M
P/E-
50d Avg. Price2.17
Div / Yield-
Payout Ratio-
EPS-0.21
Total Float42.6M
Benzinga - 2 days ago
Benzinga - Jun 13, 2022, 7:45AM
Benzinga - Jun 1, 2022, 7:02AM
Benzinga - May 4, 2022, 10:41AM
Benzinga - May 4, 2022, 10:15AM
Benzinga - May 4, 2022, 6:39AM
Benzinga - May 3, 2022, 5:19PM
Benzinga - Apr 29, 2022, 7:05AM
Benzinga - Mar 8, 2022, 4:22PM
Benzinga - Mar 8, 2022, 4:21PM
Benzinga - Feb 1, 2022, 7:05AM
Benzinga - Jan 18, 2022, 10:57AM
Benzinga - Jan 18, 2022, 7:03AM
Benzinga - Dec 21, 2021, 6:37AM
load more
Sector: Health Care.Industry: Health Care Equipment & Supplies
CytoSorbents Corp is a critical care immunotherapy leader commercializing its European Union approved CytoSorb blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients in around 55 countries. The company is conducting its pivotal REFRESH 2 - AKI cardiac surgery trial, designed to support U.S. FDA approval. The company's product portfolio consists of CytoSorb, ContrastSorb, VetResQ, HemoDefend and others. The company has around 19 issued U.S. patents, multiple patents issued internationally, and a broad patent application portfolio pending. Geographically it derives substantial revenue from product sales in Germany.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-02
REV
Q1 2022Est.ActualSurprise
EPS-0.120-0.210 -0.0900
REV9.730M8.692M-1.038M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

CytoSorbents Questions & Answers

Q
How do I buy CytoSorbents (CTSO) stock?
A

You can purchase shares of CytoSorbents (NASDAQ: CTSO) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are CytoSorbents's (CTSO) competitors?
Q
What is the target price for CytoSorbents (CTSO) stock?
A

The latest price target for CytoSorbents (NASDAQ: CTSO) was reported by B. Riley Securities on Wednesday, May 4, 2022. The analyst firm set a price target for 6.00 expecting CTSO to rise to within 12 months (a possible 183.02% upside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for CytoSorbents (CTSO)?
A

The stock price for CytoSorbents (NASDAQ: CTSO) is $2.12 last updated June 24, 2022, 8:00 PM UTC.

Q
Does CytoSorbents (CTSO) pay a dividend?
A

There are no upcoming dividends for CytoSorbents.

Q
When is CytoSorbents (NASDAQ:CTSO) reporting earnings?
A

CytoSorbents’s Q2 earnings are confirmed for Tuesday, August 2, 2022.

Q
Is CytoSorbents (CTSO) going to split?
A

There is no upcoming split for CytoSorbents.

Q
What sector and industry does CytoSorbents (CTSO) operate in?
A

CytoSorbents is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.